Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Caeregen Therapeutics, a regenerative medicine therapeutics company and Wacker Biotech, a contract development and manufacturing organization (CDMO), will collaborate on the development and production of CTR-107 (Noregen™), a novel regenerative ...
read more
Chime Biologics, a CDMO, announced that it has established 3-way strategic cooperation with Leads Biolabs and BeiGene to accelerate LBL-007 mAb development and manufacturing for speedy clinical advancement.
read more
Oncodesign Services, a Contract Research Organization (CRO) specialized in drug discovery and preclinical services in oncology and immuno-inflammation, announced the execution of a Preclinical License and Supply Agreement
read more
Contract development manufacturer of nanomedicines, Ardena, has joined forces with mRNA and LNP technology specialists RiboPro to form a new strategic commercial alliance aimed at delivering improvements
read more
Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, expects to double their lyophilization capacity for their fully automated, isolator-based filling line to meet new demand. A second lyophilizer will be added to the line ...
read more
Propanc Biopharma, Inc. a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced that synthetic recombinant proenzymes trypsinogen and chymotrypsinogen were successfully ...
read more
Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the development and manufacturing of postbiotics, to dsm-firmenich, ...
read more
IQVIA™, a global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, has been recognized along with the National Basketball Association and partners at Harvard, Columbia and BioReference ...
read more
Almac Group announced joining the Science Based Targets Initiative (SBTi), which defines and promotes best practice in science-based target setting. This development is the latest step taken by the Group on its path to reach net zero emissions by ...
read more
Kindeva Drug Delivery and H&T Presspart are partnering with Chiesi Group for the installation of a production line for dose counter (DC) and dose indicator (DI) devices.
read more
Discovery Life Sciences announced the launch of state-of-the-art flow cytometry clinical trial services.
read more
Phastar has become a certified B Corporation®. It comes after a stringent 12-month review to ensure protocols and procedures reflect the company’s commitment to high environment, social, and governance (EGS) standards.
read more
ABEC announced it will deliver multiple Custom Single Run (CSR®) single-use systems to Eli Lilly’s next-generation biopharmaceutical manufacturing facility in Limerick, Ireland.
read more
Biosynth, a supplier of raw materials to the life science industry, has acquired celares, a developer and manufacturer of conjugate vaccines and bioconjugate drugs, activated PEGs, and polymer-based drug delivery excipients.
read more
Broughton has launched a new Extractables and Leachables (E&L) testing service.
read more